- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01454765
Generation of Haploid Stem Cells From Human Germ Cells
December 10, 2013 updated by: Rambam Health Care Campus
Human cells are diploid (contain a double set of chromosomes).
The diploid genome is complex and therefore limits genetic research approaches in biomedical models.
To overcome this problem experimental generation of haploid stem cells has been done in animals.
The investigators aim at generating haploid stem cells from human germ cells that are a useful tool in genetic research and screening.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Human cells are diploid (contain a double set of chromosomes).
The diploid genome is complex and therefore limits genetic research approaches in biomedical models.
To overcome this problem experimental generation of haploid stem cells has been done in animal models.
haploid cells are easier for genetic manipulations, such as knock-in and knock-out of genes, and therefore should make a better experimental model.
The investigators aim at generating haploid stem cells from human haploid germ cells.
Study Type
Observational
Enrollment (Anticipated)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel, 30196
- Not yet recruiting
- Rambam Medical Center
-
Contact:
- Itay Maza, MD
- Phone Number: 050-206-2609
- Email: i_maza@rambam.health.gov.il
-
Principal Investigator:
- Itay Maza, MD
-
Rehovot, Israel, 76100
- Recruiting
- Weizmann Institute of Science
-
Contact:
- Itay Maza, MD
- Phone Number: +972-8-934-2230
- Email: itaym@weizmann.ac.il
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Male volunteers
Description
Inclusion Criteria:
- males over the age of 18 and under 50
- no known chronic illness
- not taking any chronic drugs
Exclusion Criteria:
- females
- males under 18 or over 50
- any known chronic illness
- taking chronic medications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Sperm sample from healthy volunteers
|
Collected germ cells will be cultured in medium.
The germ cell cultures will be infected with reprograming factors.
Rare colonies with characteristic stem cell morphologies will be expanded.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients donated samples
Time Frame: June 2011-November 2013
|
No samples collected to date
|
June 2011-November 2013
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
No secomdary outcome
Time Frame: June 2011 - November 2013
|
June 2011 - November 2013
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Itay Maza, M.D, Rambam Health Care Campus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Anticipated)
December 1, 2014
Study Completion (Anticipated)
August 1, 2015
Study Registration Dates
First Submitted
October 16, 2011
First Submitted That Met QC Criteria
October 18, 2011
First Posted (Estimate)
October 19, 2011
Study Record Updates
Last Update Posted (Estimate)
December 11, 2013
Last Update Submitted That Met QC Criteria
December 10, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- rmb-maza0001-ctil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induced Pluripotent Stem Cells
-
Institute of Cardiometabolism and Nutrition, FranceEnrolling by invitationInduced Pluripotent Stem CellsFrance
-
National Institutes of Health Clinical Center (CC)Withdrawn
-
National Institute on Drug Abuse (NIDA)Completed
-
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingEfficacy | Transplantation | Spinal Cord Injury | Safety | Induced Pluripotent Stem Cells | Clinical Trials | Human Motor Neuron ProgenitorChina
-
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.Third Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingEfficacy | Transplantation | Spinal Cord Injury | Clinical Trial | Safety | Induced Pluripotent Stem Cells | RCT | Human Motor Neuron ProgenitorChina
-
National Institute of Diabetes and Digestive and...Terminated
-
University of AarhusCompletedMesenchymal Stem Cells
-
Ankara UniversityUnknownPlacental Transfusion | Stem Cells
-
Assaf-Harofeh Medical CenterRecruitingCirculating Hematopoietic Stem CellsIsrael
Clinical Trials on generation of stem cells
-
University of Alabama at BirminghamRecruitingDiabetes Complications | Diabetic RetinopathyUnited States
-
Wuhan Sian Medical Technology Co., LtdWuhan Union Hospital, China; Xiangyang Central Hospital; Jingzhou Central Hospital and other collaboratorsUnknownB Cell Lymphoma | Acute Lymphoblastic LeukemiaChina
-
MD Stem CellsUnknownGlaucoma | Macular Degeneration | Retinal Disease | Hereditary Retinal Dystrophy | Optic Nerve DiseaseUnited States
-
University College, LondonUnknownTendinopathy | Achilles Tendinitis | Achilles Degeneration | Achilles Tendinitis, Right Leg | Achilles Tendon Thickening | Achilles Tendinitis, Left LegUnited Kingdom
-
StemCells, Inc.WithdrawnNeuronal Ceroid LipofuscinosisUnited States
-
Hadassah Medical OrganizationCompletedAmyotrophic Lateral Sclerosis
-
Honya Medical IncChang Gung Memorial HospitalNot yet recruitingCoronary Artery DiseaseTaiwan
-
El-Rayadh Fertility CentreUnknownPremature Ovarian FailureEgypt
-
Hospital ZnojmoUnknown
-
Guangzhou General Hospital of Guangzhou Military...UnknownSpinal Cord InjuryChina